| |
| |
|
| Insider
Information: |
Ramsay David A |
| Relationship: |
Director |
| City: |
San Diego, |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
2,587,962 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$26,071,462 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
2,587,962 |
|
|
| Total
Value |
$26,071,462 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
54
|
0
|
|
Stock
price went up :
|
46
|
0
|
| Stock
price went down : |
8
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
5.8
|
0.0
|
| Percentage
Gain/Loss : |
 71.9%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Halozyme Therapeutics Inc |
HALO |
VP and Chief Financial... |
2015-02-06 |
364,320 |
|
0 |
Premium* |
|
|
Savara Inc |
SVRA |
Director |
2023-12-14 |
2,223,642 |
2012-05-09 |
0 |
Premium* |
|
|
La Jolla Pharmaceutical Co |
LJPC |
Director |
2022-08-22 |
0 |
2020-08-20 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
93 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| HALO |
Halozyme Therapeutics Inc |
Vice President & CFOOfficer |
• – – |
2004-03-11 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
256,410 |
|
- |
|
| HALO |
Halozyme Therapeutics Inc |
VP and Chief Financial Officer |
• – – |
2004-08-18 |
4 |
B |
$1.60 |
$16,000 |
D/D |
10,000 |
266,410 |
2.74 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
VP and Chief Financial Officer |
• – – |
2004-08-19 |
4 |
B |
$1.62 |
$16,200 |
D/D |
10,000 |
276,410 |
2.74 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Vice President and CFO |
• – – |
2005-01-14 |
4 |
OE |
$0.39 |
$39,000 |
D/D |
100,000 |
376,410 |
|
- |
|
| HALO |
Halozyme Therapeutics Inc |
Secretary, CFOOfficer |
• – – |
2005-01-18 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
256,410 |
|
- |
|
| HALO |
Halozyme Therapeutics Inc |
Secretary, CFO |
• – – |
2005-05-27 |
4 |
B |
$1.98 |
$19,924 |
D/D |
10,000 |
386,410 |
2.74 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Secretary, CFO |
• – – |
2005-08-23 |
4 |
B |
$1.68 |
$8,438 |
D/D |
5,000 |
391,410 |
2.74 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Secretary, CFO |
• – – |
2005-08-24 |
4 |
B |
$1.70 |
$17,000 |
D/D |
10,000 |
401,410 |
2.74 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Secretary, CFO |
• – – |
2007-05-14 |
4 |
AS |
$10.19 |
$101,900 |
D/D |
(10,000) |
391,410 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Secretary, CFO |
• – – |
2007-06-14 |
4 |
AS |
$10.06 |
$101,043 |
D/D |
(10,000) |
381,410 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Secretary, CFO |
• – – |
2007-07-16 |
4 |
AS |
$9.74 |
$98,895 |
D/D |
(10,000) |
371,410 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Secretary, CFO |
• – – |
2007-07-26 |
4 |
OE |
$0.39 |
$11,700 |
D/D |
30,000 |
401,410 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Secretary, CFO |
• – – |
2008-03-18 |
4 |
B |
$4.50 |
$45,565 |
D/D |
10,000 |
411,410 |
2.74 |
- |
|
| SVRA |
Savara Inc |
Director |
– • – |
2012-05-09 |
4 |
B |
$0.55 |
$5,500 |
D/D |
10,000 |
10,000 |
2.39 |
- |
|
| SVRA |
Savara Inc |
Director |
– • – |
2012-05-10 |
4 |
B |
$0.57 |
$22,612 |
D/D |
40,000 |
50,000 |
2.39 |
- |
|
| SVRA |
Savara Inc |
Director |
– • – |
2012-05-14 |
4 |
B |
$0.54 |
$26,965 |
D/D |
50,000 |
100,000 |
2.39 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
VP and Chief Financial Officer |
• – – |
2013-05-20 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
105,000 |
|
- |
|
| HALO |
Halozyme Therapeutics Inc |
VP and Chief Financial Officer |
• – – |
2013-09-16 |
4 |
OE |
$0.39 |
$50,700 |
D/D |
130,000 |
236,735 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
VP, Chief Financial Officer |
• – – |
2013-12-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,419 |
243,154 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
VP and Chief Financial Officer |
• – – |
2014-02-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,125 |
246,279 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
VP and Chief Financial Officer |
• – – |
2014-02-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,213 |
248,492 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
VP and Chief Financial Officer |
• – – |
2014-09-16 |
4 |
OE |
$2.05 |
$102,500 |
D/D |
50,000 |
298,492 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
VP and Chief Financial Officer |
• – – |
2014-09-16 |
4 |
B |
$8.90 |
$222,500 |
D/D |
25,000 |
323,492 |
2.74 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
VP and Chief Financial Officer |
• – – |
2014-12-01 |
4 |
OE |
$2.02 |
$40,517 |
D/D |
20,058 |
343,550 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
VP and Chief Financial Officer |
• – – |
2014-12-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
17,625 |
361,175 |
0 |
- |
|
93 Records found
|
|
Page 1 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
